ADAPTIVE BIOTECHNOLOGIES CORPORATION Increase (Decrease) in Prepaid Expense and Other Assets
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) reported Increase (Decrease) in Prepaid Expense and Other Assets of $2.53 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-04
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $1.70M, a 242.45% increase year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $824.00K.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$799.00K.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $2.52M, a 80.41% increase year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in prepaid expense and other assets for fiscal 2025 was $1.73M.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$83.00K, a 104.30% decline from fiscal 2023.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in prepaid expense and other assets for fiscal 2023 was $1.93M.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$3.55M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $2.53M 10-Q · filed 2026-08-04 | $1.73M derived: sum of 3 quarters · filed 2026-08-04 | $4.25M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $824.00K 10-Q · filed 2026-05-05 | $25.00K derived: sum of 2 quarters · filed 2026-05-05 | $2.55M derived: sum of 3 quarters · filed 2026-05-05 | $3.05M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$799.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.73M derived: sum of 2 quarters · filed 2026-02-26 | $2.22M derived: sum of 3 quarters · filed 2026-08-04 | $1.73M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.02M derived: sum of 2 quarters · filed 2026-08-04 | $2.53M 10-Q · filed 2025-11-05 | $1.57M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $497.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $8.00K 10-Q · filed 2026-08-04 | -$952.00K derived: sum of 3 quarters · filed 2026-08-04 | $447.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$489.00K 10-Q · filed 2026-05-05 | -$1.45M derived: sum of 2 quarters · filed 2026-05-05 | -$50.00K derived: sum of 3 quarters · filed 2026-05-05 | $948.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$960.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $439.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.44M derived: sum of 3 quarters · filed 2026-02-26 | -$83.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.40M derived: sum of 2 quarters · filed 2025-11-05 | $877.00K 10-Q · filed 2025-11-05 | -$1.16M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $998.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$522.00K 10-Q · filed 2025-08-05 | -$2.56M derived: sum of 3 quarters · filed 2026-02-26 | $1.77M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$1.52M 10-Q · filed 2025-05-01 | -$3.55M derived: sum of 2 quarters · filed 2026-02-26 | $776.00K derived: sum of 3 quarters · filed 2026-02-26 | $58.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$2.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.30M derived: sum of 2 quarters · filed 2026-02-26 | $1.58M derived: sum of 3 quarters · filed 2026-02-26 | $1.93M 10-K · filed 2026-02-26 |
| 2023-09-30 | $4.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $3.61M derived: sum of 2 quarters · filed 2024-11-07 | $3.96M 10-Q · filed 2024-11-07 | $1.01M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$718.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$366.00K 10-Q · filed 2024-08-01 | -$3.32M derived: sum of 3 quarters · filed 2025-03-03 | -$3.27M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $352.00K 10-Q · filed 2024-05-07 | -$2.60M derived: sum of 2 quarters · filed 2025-03-03 | -$2.56M derived: sum of 3 quarters · filed 2025-03-03 | -$2.24M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$2.95M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$2.91M derived: sum of 2 quarters · filed 2025-03-03 | -$2.59M derived: sum of 3 quarters · filed 2025-03-03 | -$3.55M 10-K · filed 2025-03-03 |
| 2022-09-30 | $43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $361.00K derived: sum of 2 quarters · filed 2023-11-09 | -$601.00K 10-Q · filed 2023-11-09 | -$4.13M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $318.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$644.00K 10-Q · filed 2023-08-02 | -$4.17M derived: sum of 3 quarters · filed 2024-02-29 | $65.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$962.00K 10-Q · filed 2023-05-03 | -$4.49M derived: sum of 2 quarters · filed 2024-02-29 | -$253.00K derived: sum of 3 quarters · filed 2024-02-29 | -$975.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $709.00K derived: sum of 2 quarters · filed 2024-02-29 | -$13.00K derived: sum of 3 quarters · filed 2024-02-29 | -$1.29M 10-K · filed 2024-02-29 |
| 2021-09-30 | $4.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $3.51M derived: sum of 2 quarters · filed 2022-11-03 | $2.24M 10-Q · filed 2022-11-03 | -$285.00K derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | -$722.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$2.00M 10-Q · filed 2022-08-03 | -$4.52M derived: sum of 3 quarters · filed 2023-02-14 | $3.57M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | -$1.27M 10-Q · filed 2022-05-04 | -$3.80M derived: sum of 2 quarters · filed 2023-02-14 | $4.29M derived: sum of 3 quarters · filed 2023-02-14 | $3.62M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | -$2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $5.57M derived: sum of 2 quarters · filed 2023-02-14 | $4.89M derived: sum of 3 quarters · filed 2023-02-14 | $1.36M 10-K · filed 2023-02-14 |
| 2020-09-30 | $8.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $7.41M derived: sum of 2 quarters · filed 2021-11-03 | $3.89M 10-Q · filed 2021-11-03 | $5.62M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | -$680.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$4.21M 10-Q · filed 2021-08-04 | -$2.47M derived: sum of 3 quarters · filed 2022-02-15 | $3.49M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | -$3.53M 10-Q · filed 2021-05-05 | -$1.79M derived: sum of 2 quarters · filed 2022-02-15 | $4.17M derived: sum of 3 quarters · filed 2022-02-15 | $1.32M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $7.69M derived: sum of 2 quarters · filed 2022-02-15 | $4.84M derived: sum of 3 quarters · filed 2022-02-15 | $8.58M 10-K · filed 2022-02-15 |
| 2019-09-30 | $5.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $3.11M derived: sum of 2 quarters · filed 2020-11-10 | $6.84M 10-Q · filed 2020-11-10 | $6.24M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | -$2.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $883.00K 10-Q · filed 2020-08-10 | $285.00K derived: sum of 3 quarters · filed 2021-02-24 | $837.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $3.73M 10-Q · filed 2020-05-12 | $3.13M derived: sum of 2 quarters · filed 2021-02-24 | $3.69M derived: sum of 3 quarters · filed 2021-02-24 | |
| 2018-12-31 | -$598.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$46.00K derived: sum of 2 quarters · filed 2021-02-24 | $318.00K 10-K · filed 2021-02-24 | |
| 2018-09-30 | $552.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $916.00K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $364.00K 10-Q · filed 2019-08-13 | |||
| 2017-12-31 | $327.00K 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |